skip to content

Axis 1 / Subject 2 - Assessment and selection mechanisms for international MEG sources

Presentations:
 

Recommendations by the MSF Workshop on improvement to access for quality medicines

Speaker

Élodie JAMBERT, pharmacist, pharmacists coordinator of the Médecins Sans Frontières « Campaign for Access to Medicines ».

General scheme of the Presentation

Report on the workshop organised by the MSF Campaign for Access to Medicines held on the 10th and 11th June 2010, on the problem of sub-standard (medicines).

Essential questions on which the presentation is based

What types of collaboration can be envisaged for applying the recommendations made by the workshop?

 

Activities of the « Inter Agency Group »

Speaker

Joëlle DAVIAUD, pharmacist, Quality Assurance Manager, Global Fund (Geneva).

General scheme of the Presentation
  • Presentation of the Inter-Agency Group, its members, activities, and tools.
  • Discussion of circulation of information between members of the Group (i.e., production site quality, product / producer pairs) and confidentiality.
  • The Inter Agency Group is made up of agencies and organisations involved in MEG supplying for countries with low and middle incomes.
  • There are 5 members: UNICEF, CICR, WHO, MSF, the International Union against Tuberculosis and Lung Disease.
  • Each member carries out GMP audits of manufacturers and quality assessments for medicines destined for low and middle income countries purchased from suppliers (« product evaluation »)
  • They share the results of these various assessments within the Group.
Essential questions on which the presentation is based
  • Is opening the Inter Agencies Group to other actors possible?
  • Is it a model which can be reproduced?
 

Do the international supply agencies all have the same approach to quality?

Speaker

Christophe PERRIN, pharmacist, consultant, experience in clinical trials, MEG supply chain management, quality management (Quality Assurance).

General scheme of the Presentation
  • Presentation of the selection mechanisms for sources of some international procurement agencies and discussion of the reliability of systems set up.
  • As part of technical assistance missions to EG supply in Zimbabwe and in the Democratic Republic of the Congo, AEDES has supported the carrying out by some international supply agencies supplying MEG to low or middle income countries of AQ audits (IDA, MissionPharma, UNICEF Supply Division). This support has been provided for both purchasing organisations (FEDCAME, in the Democratic Republic of Congo) and for national pharmaceutical regulatory authorities (MCAZ in Zimbabwe).
  • Christophe Perrin provided technical support for one of these approaches.
Essential questions on which the presentation is based
  • Is it possible to delegate quality (quality assurance) to international supply agencies?
  • How can this essential function be delegated?
 

Proposal for a traceability system for sources of medicines

Speaker

Jean-Michel LICHTENBERGER, Managing Director of SMI (private wholesaler in France, active in supplying specific circuits in Africa and elsewhere: industry, large companies, airline companies...).

General scheme of the Presentation

As part of its activities in distributing medical kits to air companies, SMI has drawn up and applied an innovative and up to date system for tracing sources of medicines.  The principles of the system will be presented and opened to discussion with the aim of widening the scope of the idea.

Essential questions on which the presentation is based

Which of the actors involved in MEG supply would be ready to apply such a system?